For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
1
views
0
references
 Top references
cited by
1
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      330
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Expression of PD-L1 in Patients With Malignant Peritoneal Mesothelioma: A Pilot Study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Frequency of PD-L1 expression and the role of immunotherapy in malignant peritoneal mesothelioma (MPM) have not been well characterized. The purpose of this study was to determine PD-L1 expression in patients with MPM and perform an exploratory analysis for associations between PD-L1 and its biological behavior in MPM.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): J Surg Res
          Title: The Journal of surgical research
          Publisher: Elsevier BV
          ISSN (Electronic): 1095-8673
          ISSN (Print): 0022-4804
          Publication date (Electronic): Sep 2022
          Volume: 277
          Affiliations
          [1 ] Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
          [2 ] Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
          [3 ] Biostatistics Division, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
          [4 ] Biostatistics Division, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey; Department of Biostatistics and Epidemiology Rutgers School of Public Health, Piscataway, New Jersey.
          [5 ] Department of Pathology, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
          [6 ] Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. Electronic address: ha364@cinj.rutgers.edu.
          Article
          Publisher Item ID: S0022-4804(22)00187-1
          DOI: 10.1016/j.jss.2022.04.005
          PubMed ID: 35489218
          SO-VID: 6f0478ca-2204-466b-a062-88b083e77761
          History

          Keywords: PD-L1,CRS-HIPEC,Immunotherapy,Malignant peritoneal mesothelioma
          Data availability:
          Keywords: PD-L1, CRS-HIPEC, Immunotherapy, Malignant peritoneal mesothelioma

          Comments

          Comment on this article